
Malgorzata A. Walicka
Examiner (ID: 315)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 345 |
| Issued Applications | 187 |
| Pending Applications | 28 |
| Abandoned Applications | 130 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17836362
[patent_doc_number] => 20220273667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => PI3K INHIBITOR FOR USE IN THE THERAPY OF B CELL LYMPHOMA
[patent_app_type] => utility
[patent_app_number] => 17/612709
[patent_app_country] => US
[patent_app_date] => 2020-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5151
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612709
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/612709 | PI3K INHIBITOR FOR USE IN THE THERAPY OF B CELL LYMPHOMA | Jun 30, 2020 | Pending |
Array
(
[id] => 18075862
[patent_doc_number] => 20220401474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => HDAC6-ACTIVATED MACROPHAGES, COMPOSITIONS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/623050
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17623050
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/623050 | HDAC6-activated macrophages, compositions, and uses thereof | Jun 25, 2020 | Issued |
Array
(
[id] => 16360860
[patent_doc_number] => 20200317611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => DUAL FUNCTION MOLECULES FOR HISTONE DEACETYLASE INHIBITION AND ATAXIA TELANGIECTASIA MUTATED ACTIVATION AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/910315
[patent_app_country] => US
[patent_app_date] => 2020-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16910315
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/910315 | DUAL FUNCTION MOLECULES FOR HISTONE DEACETYLASE INHIBITION AND ATAXIA TELANGIECTASIA MUTATED ACTIVATION AND METHODS OF USE THEREOF | Jun 23, 2020 | Abandoned |
Array
(
[id] => 19793286
[patent_doc_number] => 12234215
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Carbonate compound containing fluorosulfonyl group, and preparation method and use of same
[patent_app_type] => utility
[patent_app_number] => 17/610997
[patent_app_country] => US
[patent_app_date] => 2020-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4964
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610997
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/610997 | Carbonate compound containing fluorosulfonyl group, and preparation method and use of same | Jun 22, 2020 | Issued |
Array
(
[id] => 17571033
[patent_doc_number] => 11319291
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-05-03
[patent_title] => Continuous flow microfluidic process for synthesis of 3,4-dinitropyrazole
[patent_app_type] => utility
[patent_app_number] => 16/896293
[patent_app_country] => US
[patent_app_date] => 2020-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4790
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16896293
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/896293 | Continuous flow microfluidic process for synthesis of 3,4-dinitropyrazole | Jun 8, 2020 | Issued |
Array
(
[id] => 16932333
[patent_doc_number] => 20210198222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/897189
[patent_app_country] => US
[patent_app_date] => 2020-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 1069
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16897189
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/897189 | Condensed cyclic compound and organic light-emitting device including the same | Jun 8, 2020 | Issued |
Array
(
[id] => 19164744
[patent_doc_number] => 11980626
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => Compositions for treatment of breast and prostate cancer
[patent_app_type] => utility
[patent_app_number] => 16/894732
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 23
[patent_no_of_words] => 16662
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16894732
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/894732 | Compositions for treatment of breast and prostate cancer | Jun 4, 2020 | Issued |
Array
(
[id] => 16360967
[patent_doc_number] => 20200317718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => THERAPEUTICALLY ACTIVE STEROIDAL DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/893494
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26202
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16893494
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/893494 | Therapeutically active steroidal derivatives | Jun 4, 2020 | Issued |
Array
(
[id] => 19049203
[patent_doc_number] => 20240091172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => DRUG FOR ANTAGONIZING REPLICATION OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/767616
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767616
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/767616 | DRUG FOR ANTAGONIZING REPLICATION OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND APPLICATION THEREOF | Jun 2, 2020 | Pending |
Array
(
[id] => 17280860
[patent_doc_number] => 11197873
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => Azolium salts for treatment of non-muscle invasive bladder cancer
[patent_app_type] => utility
[patent_app_number] => 16/891607
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 7883
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16891607
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/891607 | Azolium salts for treatment of non-muscle invasive bladder cancer | Jun 2, 2020 | Issued |
Array
(
[id] => 16482407
[patent_doc_number] => 20200376007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/885905
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 307
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16885905
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/885905 | THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | May 27, 2020 | Abandoned |
Array
(
[id] => 16460680
[patent_doc_number] => 10844012
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => Antibacterial compounds and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/885145
[patent_app_country] => US
[patent_app_date] => 2020-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 13669
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16885145
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/885145 | Antibacterial compounds and methods of use thereof | May 26, 2020 | Issued |
Array
(
[id] => 20438601
[patent_doc_number] => 12509428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => Polymerizable fused tricyclic compounds as absorbers of UV and visible light
[patent_app_type] => utility
[patent_app_number] => 16/883199
[patent_app_country] => US
[patent_app_date] => 2020-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12946
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16883199
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/883199 | Polymerizable fused tricyclic compounds as absorbers of UV and visible light | May 25, 2020 | Issued |
Array
(
[id] => 20438601
[patent_doc_number] => 12509428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => Polymerizable fused tricyclic compounds as absorbers of UV and visible light
[patent_app_type] => utility
[patent_app_number] => 16/883199
[patent_app_country] => US
[patent_app_date] => 2020-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12946
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16883199
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/883199 | Polymerizable fused tricyclic compounds as absorbers of UV and visible light | May 25, 2020 | Issued |
Array
(
[id] => 16631871
[patent_doc_number] => 20210050525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => ORGANIC ELECTROLUMINESCENCE DEVICE AND FUSED POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE
[patent_app_type] => utility
[patent_app_number] => 16/878338
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878338
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/878338 | Organic electroluminescence device and fused polycyclic compound for organic electroluminescence device | May 18, 2020 | Issued |
Array
(
[id] => 16283708
[patent_doc_number] => 20200277310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => PODOPHYLLOTOXIN DERIVATIVES AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/878425
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878425
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/878425 | Podophyllotoxin derivatives and their use | May 18, 2020 | Issued |
Array
(
[id] => 18153049
[patent_doc_number] => 11566009
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-01-31
[patent_title] => Energetic compound embodiments and methods of making and using the same
[patent_app_type] => utility
[patent_app_number] => 16/875544
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 7463
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875544
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/875544 | Energetic compound embodiments and methods of making and using the same | May 14, 2020 | Issued |
Array
(
[id] => 16268787
[patent_doc_number] => 20200270274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/870208
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16870208
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/870208 | ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF | May 7, 2020 | Abandoned |
Array
(
[id] => 18588589
[patent_doc_number] => 11737457
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Antimicrobial and foamable alcoholic compositions
[patent_app_type] => utility
[patent_app_number] => 16/864315
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6186
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864315
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/864315 | Antimicrobial and foamable alcoholic compositions | Apr 30, 2020 | Issued |
Array
(
[id] => 17734661
[patent_doc_number] => 20220220120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => CRYSTAL FORM OF WEE1 INHIBITOR COMPOUND AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/607447
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17607447
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/607447 | Crystal form of Wee1 inhibitor compound and use thereof | Apr 29, 2020 | Issued |